Snowball logo
logo
4536

Santen Pharmaceutical Co Ltd

4536 • TSE
¥1,650.00+¥4.50  (0.27%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
266,257279,037301,965300,004291,624291,844
COGS
119,405122,468138,089136,795130,654128,126
Gross Profit
146,852156,569163,876163,209160,970163,718
Operating Expenses & Income
Operating Income
35,97632,01551,90356,23145,21545,746
Total Operating Expenses
110,876124,554111,973106,978115,755117,972
R&D Expenses
26,37728,29724,70323,46726,18526,226
Selling General & Admin Expenses
120,610134,07265,78966,10189,570-
Earnings from Continuing Operations
Interest Expense
(250)(486)(831)(1,083)(1,994)(1,983)
Interest Income
2701,1531,5724,0021,639-
Income Tax Expense
8,4279,1843,17111,6289,8819,429
Net Income
Net Income
27,218(14,948)26,64336,25637,36938,676
Supplemental
EBIT
35,866(5,313)30,70548,56449,43649,299
EBITDA
52,92111,93648,88366,51267,79467,878
In millions of JPY, except % and values per 1 share